Showing results (431-440 of 492) with videos related to

Sort By:
Pageof 50
The Journal of Clinical Endocrinology and Metabolism|July 18, 2015
Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin GeneMartin Wabitsch, Jan-Bernd Funcke, Julia von Schnurbein, et al.
Haematologica|October 12, 2019
Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphomaVictoria M Smith, Anna Dietz, Kristina Henz, et al.
Blood|October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Human Mutation|December 1, 2015
MCM3AP and POMP Mutations Cause a DNA-Repair and DNA-Damage-Signaling Defect in an Immunodeficient ChildSusanne A Gatz, Daniela Salles, Eva-Maria Jacobsen, et al.
European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.
Cancer Cell|February 8, 2011
Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathwaysLüder Hinrich Meyer, Sarah Mirjam Eckhoff, Manon Queudeville, et al.
Nature Microbiology|May 9, 2017
Linear ubiquitination of cytosolic Salmonella Typhimurium activates NF-κB and restricts bacterial proliferationSjoerd J L van Wijk, Franziska Fricke, Lina Herhaus, et al.
Molecular Cancer Therapeutics|August 9, 2013
Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumor cellsSascha Venturelli, Alexander Berger, Timo Weiland, et al.
British Journal of Haematology|August 4, 2017
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapyMichaela Kuhlen, Kirsten Bleckmann, Anja Möricke, et al.
The New England Journal of Medicine|June 14, 2023
Rare Antagonistic Leptin Variants and Severe, Early-Onset ObesityJan-Bernd Funcke, Barbara Moepps, Julian Roos, et al.
Pageof 50